Jones Financial Companies
ANIP icon

Jones Financial Companies’s ANI Pharmaceuticals ANIP Stock Holding History

Jones Financial Companies’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.9K Buy
271
+130
+92% +$10.4K ﹤0.01% 3449
2026
Q1 		$10.3K Buy
141
+33
+31% +$2.58K ﹤0.01% 3564
2025
Q4 		$8.53K Sell
108
-75
-41% -$6.49K ﹤0.01% 3287
2025
Q3 		$17K Hold
183
– – ﹤0.01% 2874
2025
Q2 		$12K Buy
183
+8
+5% +$521 ﹤0.01% 2805
2025
Q1 		$11.8K Hold
175
– – ﹤0.01% 2638
2024
Q4 		$9.67K Buy
175
+75
+75% +$4.31K ﹤0.01% 2535
2024
Q3 		$5.88K Buy
+100
New +$6.1K ﹤0.01% 2403

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's ANIP Position: Q2 2026 in Review

Jones Financial Companies increased its ANI Pharmaceuticals (ANIP) stake by 92% in Q2 2026, buying an estimated $10.4K and bringing the position to 271 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3449.

Jones Financial Companies first reported a position in ANIP in Q3 2024 and has held it in 8 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Jones Financial Companies held 271 shares of ANI Pharmaceuticals worth $22.9K as of Q2 2026.
  • Jones Financial Companies bought 130 ANI Pharmaceuticals shares in Q2 2026, an estimated $10.4K.
  • ANI Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3449 holding.
  • Jones Financial Companies first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.